麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Oct 8 2025

Full Issue

Jury Finds J&J Liable In Baby Powder Cancer Case, Awards $966M

Johnson & Johnson plans to appeal the verdict. Other pharma and tech news is on Peter Marks joining Eli Lilly; the first "accurate blood test" to detect chronic fatigue syndrome; the effectiveness of tramadol; and more.

Johnson & Johnson was told by a California jury to pay $966 million to the family of a deceased woman who blamed her cancer on life-long use of the company鈥檚 baby powder in the largest verdict for a single user in the 15-year litigation. The Los Angeles state court jury late Monday found J&J liable for Mae Moore鈥檚 mesothelioma 鈥 a cancer tied to asbestos exposure 鈥 and awarded her $16 million in compensatory damages and $950 million in punitive damages. Moore died in 2021 at age 88. The award will go to her family, who alleged J&J hid the health risks of its iconic powder. (Feeley, 10/7)

More pharma and tech news 鈥

Peter Marks, the former top vaccine regulator at the Food and Drug Administration, has joined Eli Lilly to oversee molecule discovery and infectious diseases 鈥斅燼 move that quickly drew criticism for the revolving door between the agency and industry. (Lawrence, 10/7)

Zimmer Biomet announced on Tuesday that it has completed its acquisition of orthopedic robotics company Monogram Technologies. When the proposed deal was announced in July, Zimmer Biomet said it would acquire all outstanding shares of Monogram stock for $4.04 per share in cash, which is worth an estimated $177 million in equity value and $168 million in enterprise value. (Dubinsky, 10/7)

Scientists say they have developed the world鈥檚 first blood test to diagnose myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). There is currently no test for the condition and patients tend to be diagnosed based on symptoms, which means many can go undiagnosed for years. (Gregory, 10/8)

A new engineered molecule shows promise as an antidote for carbon monoxide poisoning with fewer side effects than other remedies currently being tested, according to research from the University of Maryland School of Medicine. (Hille, 10/7)

Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new study suggests that the medication鈥檚 potential risks outweigh its 鈥渓imited鈥 benefits for chronic pain and that the use of it should be minimized. (Howard, 10/7)

President Trump went far beyond the science when, based on an unproven link and inconclusive studies, he warned last month that taking the pain reliever acetaminophen, the active ingredient in Tylenol, during pregnancy caused autism. But for decades, doctors and scientists have sounded an alarm about a different risk associated with acetaminophen products that is well established: liver damage from accidentally overdosing on the drug. (Robbins, 10/7)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优